BAXTER INTERNATIONAL INC(BAX)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

BAXTER INTERNATIONAL INC (BAX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores BAX at 50.1/100 on a 32-signal composite quality model, placing it at rank #1,621 of 2,962 stocks — the bottom half of the AI-ranked universe. BAX scores in the top quartile across revenue scale (87.6), institutional flow (81.5). Areas of concern include profitability (18.7) and balance sheet strength (22.7), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), BAXTER INTERNATIONAL INC reports quarterly revenue of $3.0B, net income of $126.0M. Top institutional holders of BAX by reported 13-F value include BlackRock, PZENA INVESTMENT MANAGEMENT, DODGE & COX, based on the most recent SEC filings. BAX trades on the NYSE exchange and files with the SEC under CIK 10456. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BAX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for BAXTER INTERNATIONAL INC directly from SEC EDGAR.

AI Quality Score

50.1/100

AI Rank

#1,621

Revenue

$3.0B

Net Income

$126.0M

BAX key financials by period

BAXTER INTERNATIONAL INC reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202510-K$11.2B$-957.0M-2.7%
FY 202410-K$10.6B$-649.0M0.1%
FY 202310-K$10.4B$2.7B6.8%
FY 202210-K$10.1B$-2.4B-28.3%
FY 202110-K$12.1B$1.3B11.1%
FY 202010-K$11.7B$1.1B13.8%

Institutions holding BAX

Institutional investors reporting a position in BAXTER INTERNATIONAL INC on SEC Form 13F.
InstitutionSharesValueReported
BlackRock81,842,105$1.7B2026-06-30
PZENA INVESTMENT MANAGEMENT65,295,393$1.4B2026-06-30
DODGE & COX58,386,345$1.2B2026-06-30
FMR53,913,831$1.1B2026-06-30
VANGUARD CAPITAL MANAGEMENT33,754,280$719.6M2026-06-30
VANGUARD PORTFOLIO MANAGEMENT24,057,190$512.9M2026-06-30
STATE STREET20,600,468$439.4M2026-06-30
GREENHAVEN ASSOCIATES14,285,228$304.6M2026-06-30
GEODE CAPITAL MANAGEMENT14,123,689$300.6M2026-06-30
Invesco Ltd.12,361,881$263.6M2026-06-30
BAX

BAXTER INTERNATIONAL INC

BAX
NYSELarge CapHealthcare

13F Pro Quality Score

50.1/100

Rank #1,621 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

40.4/100

Profitability

18.7/100

Balance Sheet

22.7/100

Earnings Quality

67.9/100

Free Cash Flow

58.8/100

Institutional Flow

81.5/100

Revenue Scale

87.6/100

Dilution Risk

56.1/100

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$2.96B

Net Income

Q2 2026
EDGAR

$126.00M

EPS (Diluted)

Q2 2026
EDGAR

$0.24

ROIC

Q2 2026
EDGAR

12.3%

Top Institutional Holders

as of Q2 2026
$12.02B total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…